10 Best NASDAQ Stocks Under $5 to Buy Right Now
On April 28, Gabelli's John Belton joined 'Closing Bell Overtime' on CNBC to discuss how market expectations and overall investor sentiment have improved recently.
Rocket Pharmaceuticals Inc. (RCKT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Maverick Capital Lee Ainslie | 3,567,372 | $12,771,192 | +42% | 0.15% |
| 2. | Newtyn Management Noah Levy And Eugene Dozortsev | 3,165,900 | $11,333,922 | +20% | 1.21% |
| 3. | Millennium Management Israel Englander | 3,118,124 | $11,162,884 | +75% | 0% |
| 4. | AQR Capital Management Cliff Asness | 3,069,930 | $10,990,350 | +337% | 0.01% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 3,038,715 | $10,878,600 | +11434% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.44 | 10,000 | $34,400.00 | 50,000 | 2026-01-02 | Filing | |
| $3.41 | 10,000 | $34,100.00 | 40,000 | 2025-08-27 | Filing | |
| $5.08 | 20,000 | $101,600.00 | 792,680 | 2025-04-10 | Filing | |
| $4.70 | 21,099 | $99,165.30 | 26,774 | 2025-04-09 | Filing | |
| $14.75 | 1,355,932 | $19,999,997.00 | 17,628,567 | 2022-10-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.09 | 55,684 | $171,840.82 | 1,061,724 | 2026-05-21 | Filing | |
| $3.01 | 2,409 | $7,260.73 | 1,040,918 | 2026-05-19 | Filing | |
| $3.01 | 662 | $1,995.27 | 677,977 | 2026-05-19 | Filing | |
| $3.01 | 384 | $1,157.38 | 89,780 | 2026-05-19 | Filing | |
| $3.61 | 3,361 | $12,119.77 | 678,639 | 2026-05-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,687,772 | $63,322,224 | 0.63% | |
| 2. | 7,834,795 | $28,048,565 | 0% | |
| 3. | 5,107,708 | $18,285,595 | 0.01% | |
| 4. | 4,690,215 | $16,790,970 | 0% | |
| 5. | 4,485,989 | $16,059,841 | 0% |
News See All
10 Penny Stocks with Potential to Rise 1000 Percent
Penny stocks can produce eye-catching bursts of upside, but their record against the broader market is usually weaker once you zoom out.
Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best single digit stocks to buy according to analysts.
12 Best Single Digit Stocks to Buy According to Analysts
On January 27, Matt Stucky of Northwestern Mutual appeared on CNBC's 'Closing Bell Overtime' to discuss the shifting landscape of the 2026 stock market with a focus on the broadening of investor interest...
Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the stocks that will double in 2026.
20 Stocks That Will Double in 2026
On December 8, Kevin Mahn of Hennion & Walsh appeared on CNBC's 'Closing Bell Overtime' to discuss the potential for another bullish year, but with more volatility.
Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now?
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best NASDAQ stocks under $5 to buy now.
11 Best NASDAQ Stocks Under $5 to Buy Now
On October 9, Scott Ladner, Chief Investment Officer at Horizon Investments, appeared on CNBC to suggest that AI remains the key market driver along with tech.
Jefferies Raises PT on Rocket Pharmaceuticals, Inc. (RCKT) to $3.00; Maintains ‘Hold’ Rating
With significant hedge fund interest and a share price under $10, Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals Reorganizes, Cuts Workforce by 30% to Focus on AAV Cardiovascular Platform
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the most promising penny stocks under $5.